Uncategorised - European Medical Journal

Climatic Factors Drive Oropouche Virus Spread Across Latin America

A large-scale study has identified key predictors of Oropouche virus transmission risk across Latin America, providing insights into the 2023–24 outbreak.

Weighing up the Risks: GI Side Effects of Semaglutide vs Tirzepatide

Tirzepatide linked to more GI issues than semaglutide in new study on weight-loss drugs without diabetes. Read more!

Emerging Guidelines: Photobiomodulation in Focus

Healthcare professionals treating conditions such as peripheral neuropathy, wound ulcers, or radiation dermatitis now have fresh, evidence-based guidance on the use of photobiomodulation (PBM) therapy.

5 minutes with... Dr Tami Nussbaum, Takeda

Dr Tami Nussbaum, shares why she left medicine for pharma, the challenges of rare disease and how she avoids burnout.

Which Biologic is Best for Psoriasis Treatment?

A recent clinical trial has compared the effectiveness of IL-17 and IL-23 biologics in treating moderate to severe plaque psoriasis.

Intensive Blood Pressure Control Cuts Dementia Risk by 15%

Blood pressure control over 48 months cuts dementia risk by 15% in a large clinical trial.

Intraoperative Urine Output Similar with Volatile and IV Anaesthesia

Volatile anaesthetics and propofol show no significant difference in intraoperative urine output, study suggests.

Nasal Epithelial Assays Predict Cystic Fibrosis Clinical Outcomes

A new study supports the clinical utility of human nasal epithelial cultures as predictive biomarkers for cystic fibrosis CFTR modulator therapy.

What Physicians Need to Know Before Recommending TORS

In a significant update for head and neck oncology care, new clinical insights into transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma (OPC) aim to guide U.S. physicians in tailoring treatment plans through a multidisciplinary lens.

Advanced CT Interpretation Aids Treatment Planning in MSI-H Colon Cancer

CT pattern analysis improves diagnosis and predicts immunotherapy success in MSI-H colon cancer. Read more!